| Chad D Denamur, DPM | |
|
1110 Kepler Dr, Green Bay, WI 54311-8306 | |
| (920) 288-5555 | |
| (920) 288-5550 |
| Full Name | Chad D Denamur |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 27 Years |
| Location | 1110 Kepler Dr, Green Bay, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972557817 | NPI | - | NPPES |
| 43229500 | Medicaid | WI | |
| 1972557817 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 805 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Baycare Medical Ctr | Green bay, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baycare Clinic Llp | 4385554328 | 185 |
News Archive
St George's, University of London has signed an exclusive worldwide licensing agreement with rare-disease research-and-development firm Orphan Technologies Ltd to develop new therapies for deadly metabolic disorders.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced that it has notified the US Food and Drug Administration (FDA) that the company has placed a voluntary hold on PEARL-SC, the Phase 2b study of A-623 for the treatment of Systemic Lupus Erythematosus (lupus), due to problems found with product vials.
Patients with cancer face a serious dilemma during the COVID-19 pandemic, as staying at home could increase their risk of cancer progression, while visiting the hospital for treatment could increase their risk of becoming infected with the virus that causes COVID-19.
The National Science Foundation has awarded the University of Pennsylvania a $24 Million, five-year grant to establish a Science and Technology Center focused on engineering mechanobiology, or the way cells exert and are influenced by the physical forces in their environment.
› Verified 3 days ago
| Provider Name | Baycare Clinic Llp |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1588609648 PECOS PAC ID: 4385554328 Enrollment ID: O20031105000087 |
News Archive
St George's, University of London has signed an exclusive worldwide licensing agreement with rare-disease research-and-development firm Orphan Technologies Ltd to develop new therapies for deadly metabolic disorders.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced that it has notified the US Food and Drug Administration (FDA) that the company has placed a voluntary hold on PEARL-SC, the Phase 2b study of A-623 for the treatment of Systemic Lupus Erythematosus (lupus), due to problems found with product vials.
Patients with cancer face a serious dilemma during the COVID-19 pandemic, as staying at home could increase their risk of cancer progression, while visiting the hospital for treatment could increase their risk of becoming infected with the virus that causes COVID-19.
The National Science Foundation has awarded the University of Pennsylvania a $24 Million, five-year grant to establish a Science and Technology Center focused on engineering mechanobiology, or the way cells exert and are influenced by the physical forces in their environment.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chad D Denamur, DPM 1035 Kepler Dr, Green Bay, WI 54311-8320 Ph: () - | Chad D Denamur, DPM 1110 Kepler Dr, Green Bay, WI 54311-8306 Ph: (920) 288-5555 |
News Archive
St George's, University of London has signed an exclusive worldwide licensing agreement with rare-disease research-and-development firm Orphan Technologies Ltd to develop new therapies for deadly metabolic disorders.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced that it has notified the US Food and Drug Administration (FDA) that the company has placed a voluntary hold on PEARL-SC, the Phase 2b study of A-623 for the treatment of Systemic Lupus Erythematosus (lupus), due to problems found with product vials.
Patients with cancer face a serious dilemma during the COVID-19 pandemic, as staying at home could increase their risk of cancer progression, while visiting the hospital for treatment could increase their risk of becoming infected with the virus that causes COVID-19.
The National Science Foundation has awarded the University of Pennsylvania a $24 Million, five-year grant to establish a Science and Technology Center focused on engineering mechanobiology, or the way cells exert and are influenced by the physical forces in their environment.
› Verified 3 days ago
Mark Andrew Kachan, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2793 Lineville Rd, Green Bay, WI 54313 Phone: 920-496-4700 | |
Dr. Stephen Arbes, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1779 Main St, Green Bay, WI 54302 Phone: 920-465-0181 Fax: 920-465-3916 | |
Dr. Edward Patrick Vanbeek, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1771 Allouez Ave, Green Bay, WI 54311 Phone: 920-469-5522 Fax: 920-469-5560 | |
Joseph Francis Albers, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2793 Lineville Rd, Green Bay, WI 54313 Phone: 920-496-4700 | |
Glenn A Hansen, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 2331 S Oneida St, Green Bay, WI 54304 Phone: 920-499-1177 Fax: 920-499-5398 | |
Green Bay Podiatry Associates Sc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2036 S Ridge Rd, Green Bay, WI 54304 Phone: 920-498-0110 Fax: 920-498-3481 | |
April C Borchardt, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1821 S Webster Ave, Green Bay, WI 54301 Phone: 920-496-4700 |